Prescription Digital Therapeutics

Five pharma companies talk digital therapeutic partnerships, DTx pricing, and more

10.09.20

21 min. Read

Pharma execs talk digital therapeutic pricing. Germany reimburses first two prescribable apps.

10.09.20

7 min. Read

Five investors talk digital therapeutics: Red flags, starting up, and COVID–19

10.02.20

14 min. Read

Proteus founders explain. Investors talk DTx.

10.02.20

8 min. Read

Apple eyes asthma, sleep apnea SaMDs? Amwell-Teladongo suit.

9.18.20

8 min. Read

32 Pear patents. Amwell $644M IPO.

9.11.20

6 min. Read

New Teladongo merger details. Pear’s acquisitive study strategy.

9.04.20

8 min. Read

20 percent of Rx-only digital therapeutics have studies so far.

8.14.20

9 min. Read

Livongo’s IPO anniversary. DTx pipelines.

7.24.20

7 min. Read

Two UnitedHealth behavioral health acquisitions. BMS DTx launch Q3.

7.17.20

7 min. Read